cisplatin,pembrolizumab,enfortumab vedotin
astellas,seagen,merck
['vedo', 'pembro', ' vedo', 'cisplatin', 'urothelial', 'enfortumab', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'ev-103']
pros in cisplatin-ineligible pts with locally advanced or metastatic #urothelialcancer treated with enfortumab vedotin alone or in combination with pembrolizumab in the phase 1b/2 ev-103 cohort k . #gu23 &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology